Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cervical HPV-16 and / or HPV-18 Infection”

8 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 8 of 8 results

Large-scale testing (Phase 3)Study completedNCT00929526
What this trial is testing

Extension Study of the Efficacy of the GSK 580299 Vaccine in Japanese Women Vaccinated in the Primary NCT00316693 Study

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 752
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06273553
What this trial is testing

A Study in Subjects With Human Papillomavirus 16 or 18 Associated Cervical Intraepithelial Neoplasia Grade 2 or 3

Who this might be right for
Human Papillomavirus Associated Intraepithelial NeoplasiaCervical Intraepithelial Neoplasia Grade 2/3Human Papillomavirus Type 16 Infection+1 more
RinuaGene Biotechnology Co., Ltd. 39
Large-scale testing (Phase 3)UnknownNCT02801383
What this trial is testing

Recombinant Human Interferon a-2b Gel for HPV-16 and/ or HPV-18 Gynecological Infections

Who this might be right for
Cervical HPV-16 and / or HPV-18 Infection
Lee's Pharmaceutical Limited 100
Testing effectiveness (Phase 2)Study completedNCT00689741
What this trial is testing

Efficacy Study of HPV-16/18 Vaccine (GSK 580299) to Prevent HPV-16 and/or -18 Cervical Infection in Young Healthy Women

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 1,113
Not applicableUnknownNCT04022148
What this trial is testing

The Prospective Cohort Study to Evaluate the Preventive Efficacy of HPV Vaccine in Japanese Women Aged 27-45 Years

Who this might be right for
Cancer of CervixVaccinia
University of Fukui 2,800
Large-scale testing (Phase 3)Study completedNCT00122681
What this trial is testing

Human Papilloma Virus (HPV) Vaccine Efficacy Trial Against Cervical Pre-cancer in Young Adults With GlaxoSmithKline (GSK) Biologicals HPV-16/18

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 18,729
Large-scale testing (Phase 3)Study completedNCT00128661
What this trial is testing

Vaccine To Prevent Cervical Intraepithelial Neoplasia or Cervical Cancer in Younger Healthy Participants

Who this might be right for
Cervical CancerPrecancerous Condition
GlaxoSmithKline 7,466
Testing effectiveness (Phase 2)Study completedNCT00120848
What this trial is testing

Follow-up Study of GSK Biologicals' Human Papilloma Virus (HPV) Vaccine to Prevent Cervical Infection in Young Adults

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 776